Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
A Hong Kong based fund recently exited its stake in a leading China logistics platform for about $194 million. This a...
A high-profile venture investor steps away from ETHZilla as Ethereum treasury strategies face a new era. The move spa...
A Dearborn man faces a multi-count case tied to dozens of auto-related complaints. This article breaks down the finan...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...
As AI momentum grows, savvy investors look for a foothold before Anthropic goes public. This guide breaks down three ...
A major fund recently disclosed a large move in Globalstar as the stock surged. This article explains what happened, ...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
Inflation can erode returns, but there are smarter ways to shield your portfolio. This guide shows two durable energy...
Seeking reliable income you can count on for decades? This guide highlights two blue-chip picks—Coca-Cola and Procter...
As AI infrastructure expands, two dividend stocks double right as the backbone for data centers and industrial supply...